The "8th International Conference on Future Pharma and Innovations," scheduled for September 27-28, 2023, in Amsterdam, Netherlands, and largely focused on the theme "Pioneering the Development of Future Pharma," is cordially invited to participants from all over the world.

With its well crafted systematized scientific programme, which features interactive panel discussions, keynote lectures, grand addresses, and bill Sessions, the event provides its audience with a chic stage. The Future of Pharma R&D, Industrial Pharmacy and Physical Drugstore, Drug Discovery and Development, Novel Drug Delivery Systems, and Pharma and Biotech Financial Outlook are some of the topics covered by the global platform Future Pharma.

Read on futurepharmameetings.pharmaceuticalconferences.com

Arena International are delighted to announce the Outsourcing in Clinical Trials Southern California Event will be returning to California’s La Jolla on September 26th & 27th 2023! Our leading clinical show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed- take a look at our agenda page & list of keynote speakers. The 2023 program boasts 2 streams jam packed with content. The Speaking Faculty includes the likes of AbbVie, Jazz Pharmaceuticals, Pfizer, Cortexyme, PTC Therapeutics, ReShape Lifesciences, Elevar Therapeuticsand many more. This is a a networking focused event with industry leading presentations, interactive formats and the most innovative solution providers attending. Attendees will hear from industry leading speakers, learn what is round the corner in terms of future trends and get the latest knowledge on new and upcoming disruptors.

Read on arena-international.com

The Fierce Clinical Summit is our flagship event for clinical professionals that covers multiple disciplines. We're bringing together attendees from three key clinical areas - Clinical Innovation, Clinical Governance and Oversight, and Clinical Quality. Professionals working with both internal and external stakeholders will come together to learn the latest innovations and best practices in their areas of concentration, plus be able to network with peers both in their area of concentration and across departments.

Read on go.evvnt.com

Growing consumer demand, technology advancement, and VC investment are feeding into the billion-dollar market opportunity for novel alternative proteins and cultured meat and seafood. To fully realize this potential, the commercial and technical burden of scale-up and downstream processing must be overcome.

The Downstream Processing (DSP) for Alternative Proteins and Cellular Agriculture Summit is your dedicated community to help you evaluate current DSP strategies to reduce cost, improve titer, and guarantee quality for commercial scalability.

Developed with leading companies in the space, here is a snapshot of this year's unmissable content across 3 hands-on workshops and 2 days of data-driven case studies: 

- Determine and define downstream processing based on the technical and commercial viability with Impossible Foods and Remilk

- Navigate the path to commercializing sustainable proteins from R and D scale with in-house process modelling with Motif FoodWorks

- Control the environment of a scaled-up growth facility for good proliferation with Orbillion Bio

- Develop scalable analytical frameworks to validate bioprocessing, characterize the product, and satisfy regulators with BlueNalu, Shiru, and Impossible Foods - - Validate contract manufacturing facilities and select the right equipment for pilot scale for smooth technology transfer with Helaina and Finless Foods

Read on go.evvnt.com

With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! However, with so many KRAS G12C drugs in clinic, the field is now turning its eyes to the next generation of RAS therapies, specifically those that can target more mutations, more RAS isoforms, and more indications And so, the 5th RAS Targeted Drug Development Summit arrives as the only industry-dedicated, end-to-end forum to accelerate your best-in-class RAS therapies from conception through to commercialization. As the only industry-dedicated, end-to-end meeting focused on the next-generation of drugs targeting RAS cancers, the 5th RAS Targeted Drug Development Summit will bring together 150+ key opinion leaders to accelerate RAS-targeted drug discovery, advance pre-clinical drugs to clinic, and optimize translational and clinical development.

Read on go.evvnt.com

The 2nd mRNA Process Development and Manufacturing Summit returns to Boston as the most comprehensive and technical industry dedicated forum, to address key industry bottlenecks from securing quality starting materials, quality by design and automated large-scale manufacturing, to ultimately reduce costs of mRNA production whilst harmonizing with regulatory expectations. 50+ world-class industry experts including leading mRNA players from Moderna, BioNTech, CureVac, Pfizer and more will take center stage across 3 jam-packed days, with 3 deep-dive content tracks on research scale, regulatory  and clinical scale, and commercial scale covering key areas from plasmid DNA manufacturing, in vitro transcription, purification and mRNA drug product development to help accelerate your mRNA drugs into the clinic and through to market.   Join 250+ VPs, Directors and Heads of Process Development, Drug Substance, CMC, and MSAT at the world's only end-to-end meeting enabling scalable, cost-effective and commercially viable global mRNA production.

Read on go.evvnt.com

The National Academy of Medicine, with support from Johnson & Johnson Innovation, is hosting the 3rd annual virtual Healthy Longevity Global Innovator Summit on September 26-27, 2023. This global gathering fosters innovation in healthy aging, featuring insights from diverse stakeholders and highlighting projects by past awardees. Key themes include health equity, AI, and funding opportunities, with extensive networking opportunities for international Catalyst Awardees to connect with collaborators, mentors, and funders.

Read on nam.org 

The Viral Vector Characterization & Analytical Development Summit in 2023 marks a pivotal moment in the industry as it witnesses a renaissance in viral vector characterization. With increased complexity and the need for precision, this summit brings together industry leaders in characterization, analytical development, formulation, and quality to optimize process development and accelerate vector scale-up. Join top companies such as Ultragenyx, Kite Pharma, and Pfizer for a 3-day agenda tackling the biggest bottlenecks in this rapidly evolving field. Stay ahead of the curve and seize cross-learning opportunities to benchmark your work and transform workflows.

Read on go.evvnt.com

The Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments. In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments. Nationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing afflicted patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.

Read on go.evvnt.com

Magnus Group is ecstatic to announce its online event “7th Edition of World Nanotechnology Conference” (Nanotechnology 2023) which is scheduled as the HYBRID EVENT during September 25-27, 2023 at Valencia, Spain.

This Hybrid mode allows you to participate as in-person in Valencia, Spain or Virtual from your home or work.

The summit encircles the theme “MINI: Multilateral Inquisitions in Nanotech Innovations.”

This versatile and insightful congress will serve as the premier interdisciplinary forum for scientists, researchers, nanotechnologists, chemists, physicists, healthcare professionals, pharmacists, clinicians, practitioners, industry giants, and educators to present and discuss the most recent innovations, trends, practical challenges, and solutions in the field. It will provide them with the chance to share information on their most recent research and innovation, network, discover new collaborators, learn about the present status of nanotechnology, and discuss future research directions with other professionals in the international community. Attendees will have access to cutting-edge topics through our Keynote sessions, Oral and Poster Presentations, Workshops/Symposiums, and other interactive and informal sessions. This flagship event will provide attendees with a unique overview of global research efforts in the field of nanoscience and nanotechnology by accepting presentations from all over the world, enriching conversations and networking.

Throughout the three-day scientific gathering, the delegates will echo the common sentiment that nanotechnology is expected to be the next big thing in the future. We hope you will find NANOTECHNOLOGY 2023 insightful, enlightening, and delightful.

Read on magnusconferences.com